Drug information provided by: Merative, Micromedex®
Enfortumab vedotin-ejfv injection is used to treat urothelial cancer (bladder cancer) that has spread or cannot be removed by surgery. This medicine is used in combination with pembrolizumab. It is also used alone in patients who have tried other cancer medicines (eg, immunotherapy medicine, platinum-containing cancer medicine) or in patients who are not able to receive a cancer medicine that contains cisplatin and have received one or more prior treatments.
This medicine is to be given only by or under the supervision of your doctor.
This product is available in the following dosage forms:
Portions of this document last updated: Feb. 01, 2024
Copyright: © Merative US L.P. 1973, 2024. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift can go twice as far to advance cancer research and care!